| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.0067 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |